Cardiovascular risk in patients with inflammatory bowel diseases: a review

被引:6
作者
Manea, Maria [1 ]
Marcu, Dragos [1 ,3 ]
Motofei, Ion [2 ,3 ]
Socea, Bogdan [2 ,3 ]
Stoian, Anca Pantea [3 ]
Bratu, Ovidiu Gabriel [1 ,3 ]
Gaman, Mihnea-Alexandru [3 ]
Gaman, Amelia Maria [4 ]
Stanescu, Ana Maria Alexandra [3 ]
Nicorici, Lucia Mazur [5 ]
Diaconu, Camelia Cristina [3 ,6 ]
机构
[1] Emergency Univ Cent Mil Hosp, Bucharest, Romania
[2] St Pantelimon Clin Emergency Hosp, Bucharest, Romania
[3] Carol Davila Univ Med & Pharm, Bucharest, Romania
[4] Univ Med & Pharm Craiova, Filantropia City Hosp, Craiova, Romania
[5] State Univ Med & Pharm Nicolae Testemitanu, Kishinev, Moldova
[6] Clin Emergency Hosp Bucharest, Bucharest, Romania
来源
ROMANIAN BIOTECHNOLOGICAL LETTERS | 2019年 / 24卷 / 02期
关键词
Inflammatory bowel diseases; cardiovascular events; thromboembolic events; atherosclerosis; HIGH-DENSITY-LIPOPROTEIN; ENDOTHELIAL DYSFUNCTION; HEART-DISEASE; POPULATION; EPIDEMIOLOGY; EVENTS; ATHEROSCLEROSIS; HOMOCYSTEINE; PREVALENCE; PREDICTORS;
D O I
10.25083/rbl/24.2/366.373
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Patients with inflammatory bowel diseases (IBD) have an increased risk of cardiovascular events (myocardial infarction, cerebrovascular events and death of cardiovascular causes), because of some common pathophysiological mechanisms. Patients with IBD have high levels of cytokines, C-reactive protein and homocysteine, leading to endothelial dysfunction and atherosclerosis. Also, the increased levels of coagulation factors in patients with IBD lead to an increased risk for thromboembolic events. There are numerous studies that sustain the link between IBD and cardiovascular complications.
引用
收藏
页码:366 / 373
页数:8
相关论文
共 64 条
[1]   Conventional Risk Factors and Cardiovascular Outcomes of Patients with Inflammatory Bowel Disease with Confirmed Coronary Artery Disease [J].
Aggarwal, Ashish ;
Atreja, Ashish ;
Kapadia, Samir ;
Lopez, Rocio ;
Achkar, Jean-Paul .
INFLAMMATORY BOWEL DISEASES, 2014, 20 (09) :1593-1601
[2]   Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction [J].
Anderson, TJ .
HEART FAILURE REVIEWS, 2003, 8 (01) :71-86
[3]  
[Anonymous], 2002, ANN GASTROENTEROLOGY
[4]   The incidence of arterial thromboembolic diseases in inflammatory bowel disease: A population-based study [J].
Bernstein, Charles N. ;
Wajda, Andre ;
Blanchard, James F. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (01) :41-45
[5]   Dyslipidemia and lipoprotein profiles in patients with inflammatory bowel disease [J].
Biyyani, Raja Shekhar R. Sappati ;
Putka, Brian S. ;
Mullen, Kevin D. .
JOURNAL OF CLINICAL LIPIDOLOGY, 2010, 4 (06) :478-482
[6]   The epidemiology of inflammatory bowel disease [J].
Burisch, Johan ;
Munkholm, Pia .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (08) :942-951
[7]  
Checherita IA, 2012, ROM J MORPHOL EMBRYO, V53, P7
[8]  
Checherita IA, 2015, ROM J MORPHOL EMBRYO, V56, P27
[9]  
Cocolos AM, 2018, REV CHIM-BUCHAREST, V69, P134
[10]   Statins are associated with reduced use of steroids in inflammatory bowel disease: A retrospective cohort study [J].
Crockett, Seth D. ;
Hansen, Richard A. ;
Stuermer, Til ;
Schectman, Robin ;
Darter, Jane ;
Sandler, Robert S. ;
Kappelman, Michael D. .
INFLAMMATORY BOWEL DISEASES, 2012, 18 (06) :1048-1056